Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE ... Learn more here. Lilly's newest cash ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...